Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Risk of bias assessment The results of evaluating the quality of the included studies are presented in online Supplementary Fig
GLOW Dosing Protocol The standard protocol for GLOW is 2.8 mg per injection: 2 mg GHK-Cu with 400 mcg each of BPC-157 and TB-4
Off-Label Use in Men Although interest in PT-141 for men continues to grow, the FDA has not approved it for male sexual dysfunction
A 2003 study by Staresinic, Sebecic, Patrlj, and colleagues in Journal of Orthopaedic Research used a rat Achilles tendon transection model with BPC-157 administered intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg and reported improved load-to-failure, Young's modulus of elasticity, and Achilles functional index scores, reduced tendon defect size by day 14, and increased tendocyte outgrowth in vitro with specific numerical effect sizes and p-values not reported in the abstract
[Epub ahead of print] Wang AM, Pradhan S, Coughlin JM, Trivedi A, DuBois SL, Crawford JL, et al
US$ 24.67
US$ 27.39
US$ 28.85
US$ 27.48
